FFAR2 and neoplasm: By contrast, adoptive transfer of OT-I cells with CRISPR–Cas9-mediated Gpr43 knockout (Extended Data Fig. 10e) led to markedly reduced tumour growth that could not be further attenuated by TVA diet (Fig. 4f, right).